RecruitingNCT06177743
IRIS-Coroflex NEO Cohort
Evaluation of Effectiveness and Safety of Coroflex ISAR NEO Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Sponsor
Seung-Jung Park
Enrollment
1,000 participants
Start Date
Jan 9, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The objective of this study is to evaluate the effectiveness and safety of Coroflex ISAR NEO stents in comparison to other drug-eluting stents (DES) in real-world practice.
Eligibility
Min Age: 19 Years
Inclusion Criteria3
- Patients ≥ 19 years old
- Patients receiving Coroflex ISAR NEO stents.
- The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.
Exclusion Criteria3
- Patients with a mixture of other DESs
- Terminal illness with life expectancy <1 year.
- Patients with cardiogenic shock
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICECoroflex ISAR NEO stent
Percutaneous coronary intervention with Coroflex ISAR NEO stent
Locations(11)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06177743
Related Trials
Coronary Artery Disease Assessment Strategies in TAVI Patients
NCT065593321 location
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine
NCT058500911 location
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT0677963019 locations
Correlation of FFR CT With Invasive FFR in Multi-ethnic Cohort- a Retrospective Study
NCT067908361 location
Canagliflozin Targeting Vascular Inflammation
NCT054270841 location